Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials - investor.lilly.com

1. Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials  investor.lilly.com
2. Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial  Nature
3. Daily pill to help keep weight off after stopping obesity jabs  BBC
4. Patients don't regain much weight switching from injections to Lilly's weight-loss pill, study finds  Reuters
5. Daily pill could ‘keep you slim for life’  The Telegraph

from Top stories - Google News https://ift.tt/rgWpDQL